tag@treatmentactiongroup.org

HIV

HCV Elimination Among People Living with and at Risk of HIV: Challenges and Opportunities

Following the White House’s recent proposal for a National Hepatitis C Elimination Plan as part of its Fiscal Year 2024 budget request to Congress, and the fact that key populations for HIV are also at high risk of HCV, Treatment Action Group is organizing a webinar that will highlight best practices and challenges for HCV elimination with a specific focus on high-burden populations.
Read more

TAG Mourns the Loss of Dr. Stephaun Elite Wallace

TAG extends our deepest condolences to the family, friends and loved ones of Dr. Stephaun Elite Wallace, PhD, MS. Dr. Wallace was a treasure to all who knew and worked with him, and his legacy of mentorship and community engagement in the HIV research landscape will be felt for generations.
Read more
Report cover that reads" Pipeline Report 2023. Pipeline report is white text, and 2023 is gray. The main cover is black with a graphic of blue wavy lines

2023 Pipeline Report

Pipeline Report provides an overview of research and provides an overview of research and development of innovations for diagnosing, preventing, treating, and curing HIV, hepatitis C virus (HCV), and tuberculosis (TB).
Read more
Cover of TAG's 2022 Annual Report. Progress in the Fight for Better Treatment, Prevention, A Vaccine, and a Cure for HIV, Tuberculosis, and Hepatitis C Virus.

2022 Annual Report

As we close another year of unprecedented challenges and achievements, I'm honored to share with you Treatment Action Group's (TAG) 2022 Annual Report.
Read more

Research in Action Awards 2023

Save the date for Monday, October 19! TAG’s 2023 Research in Action Awards will honor some of the best and brightest activists, scientists, and leaders in the fight to end HIV, tuberculosis, and hepatitis C across the U.S. and around the world.
Read more
Back To Top